Rekvina Labs: Independent Directors Recommend Open Offer at ₹10/Share

Rekvina Laboratories Ltd announced that its Committee of Independent Directors (IDC) met on June 24, 2026, to provide recommendations on an open offer. The offer, made by Surbhit Mukesh Shah, Amit Mukesh Shah, and Dhruvalkumar Patel, aims to acquire up to 28,90,100 equity shares, representing 26% of the expanded share capital, at ₹10 per share. The total consideration is ₹2,89,01,000. The IDC has deemed the offer price fair and reasonable in accordance with SEBI SAST Regulations, though public shareholders are advised to make their own informed decisions. The committee reviewed various documents including the Public Announcement, Detailed Public Statement, and valuation reports.